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Translocations are known to affect the expression of genes at the breakpoints and, in the case of unbalanced trans-
locations, alter the gene copy number. However, a comprehensive understanding of the functional impact of this class of
variation is lacking. Here, we have studied the effect of balanced chromosomal rearrangements on gene expression by
comparing the transcriptomes of cell lines from controls and individuals with the t(11;22)(q23;q11) translocation. The
number of differentially expressed transcripts between translocation-carrying and control cohorts is significantly higher
than that observed between control samples alone, suggesting that balanced rearrangements have a greater effect on gene
expression than normal variation. Many of the affected genes are located along the length of the derived chromosome 11.
We show that this chromosome is concomitantly altered in its spatial organization, occupying a more central position in
the nucleus than its nonrearranged counterpart. Derivative 22-mapping chromosome 22 genes, on the other hand, remain
in their usual environment. Our results are consistent with recent studies that experimentally altered nuclear organiza-
tion, and indicated that nuclear position plays a functional role in regulating the expression of some genes in mammalian
cells. Our study suggests that chromosomal translocations can result in hitherto unforeseen, large-scale changes in gene
expression that are the consequence of alterations in normal chromosome territory positioning. This has consequences
for the patterns of gene expression change seen during tumorigenesis-associated genome instability and during the
karyotype changes that lead to speciation.
[Supplemental material is available online at http://www.genome.org. The gene expression data from this study have been
submitted to the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under series accession no. GSE13122.]
In addition to the millions of individual base pair changes that dis-
tinguish any two unrelated copies of our genome (The International
HapMap Consortium 2003), recent reports have also described large
numbers of copy number variable regions (CNVRs) (Redon et al.
2006; Korbel et al. 2007; Kidd et al. 2008; Conrad et al. 2009).
Nucleotide changes and copy number variation contribute to
functional variation by modifying gene expression both in cis and
in trans (Cheung et al. 2005; Merla et al. 2006; Stranger et al.
2007a,b; Guryev et al. 2008; Henrichsen et al. 2009b). Interest-
ingly, CNVRs contribute to functional variation not only by modi-
fying the expression levels of genes within the aneuploid segments
in a somewhat dosage-dependent manner (Stranger et al. 2007a;
Henrichsen et al. 2009b), but also by inducing altered expression
of genes lying near to the breakpoints, even though these do not
vary in copy number (Merla et al. 2006; Reymond et al. 2007;
Stranger et al. 2007a; Guryev et al. 2008;Molina et al. 2008; Cahan
et al. 2009; Henrichsen et al. 2009b). Consistently, these segmental
aneuploidies are often associated with human phenotypes and
diseases (for review, see Henrichsen et al. 2009a; Ionita-Laza et al.
2009; Zhang et al. 2009).
A third type of variation comprises balanced chromosomal
rearrangements, such as reciprocal translocations and inversions,
which elicit no gain or loss of genetic material. Balanced rear-
rangements occur in approximately one in 500 individuals in the
general population (Ogilvie et al. 2001), and recent studies have
identified hundreds of polymorphic inversions (Tuzun et al. 2005;
Korbel et al. 2007; Kidd et al. 2008). Approximately 6% of recip-
rocal translocations are associated with some sort of phenotype
(Warburton 1991). This may result from the direct disruption of
a gene, or genes, at the breakpoints or by dissociating genes from
their long-range regulatory elements (Kleinjan and vanHeyningen
2005). At the transcriptome level, however, the functional impact
of balanced translocations remains poorly studied.
Here, we report a comprehensive genome-wide analysis into
the effect of the t(11;22)(q23;q11) reciprocal translocation on gene
expression. This translocation between chromosome 11 (HSA11)
and 22 (HSA22) is a recurrent constitutional, non-Robertsonian
translocation (Emanuel and Saitta 2007) (see Supplemental Fig. S1),
with the vast majority of carrier families not sharing common
haplotypes (N Simon Thomas, pers. comm.). Carriers of the trans-
location are phenotypically normal, although some studies have
shown they have up to a 10-fold greater risk of developing breast
cancer than cytogenetically normal individuals (Lindblom et al.
1994; Jobanputra et al. 2005;Wieland et al. 2006; Carter et al. 2010).
Carriers are also at risk of having progeny with Emanuel syndrome
(OMIMno. 609029) (Fraccaro et al. 1980; Zackai andEmanuel 1980),
due to malsegregation of the translocation products through meio-
sis. These children inherit an unbalanced complement of the bal-
anced translocation and are partially trisomic for chromosomes 11
and 22 [+der(22)t(11;22)(q23;q11); see Supplemental Figure S1].
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At the transcriptome level, the functional impact of balanced
translocations is yet to be elucidated. However, it is known that
these translocations can impact on the spatial organization of
the derived chromosomes within the nucleus (Croft et al. 1999;
Taslerova et al. 2003, 2006). Gene regulation is dependent not only
on regulatory sequences and chromatin context located in cis, but
also on nuclear position (for review, see Cremer et al. 2006; Fraser
andBickmore 2007;Heard andBickmore2007;Meaburn andMisteli
2007). This positioning is nonrandomwith gene-rich and gene-poor
chromosomes usually located toward the nuclear interior and nu-
clear periphery, respectively (Croft et al. 1999; Boyle et al. 2001).
Consequently, HSA22 is normally more centrally positioned than
HSA11 (Boyle et al. 2001). Since the radial organization of chro-
mosomes in the nucleus impacts upon the nuclear positioning of
translocation chromosomes (Croft et al. 1999), and proximity to the
nuclear edge can directly affect gene expression inmammalian cells
(Finlan et al. 2008; Reddy et al. 2008; Deniaud and Bickmore 2009),
we reasoned that a possible repositioning of the derivative chro-
mosomes 11 and 22 in translocation cell lines could have an effect
on gene expression along the length of the derivative chromosomes.
Results and Discussion
To assess the effect of a balanced chromosomal rearrangement on
the transcriptome, we individually analyzed genome-wide ex-
pression levels, using Affymetrix expression arrays, in lympho-
blastoid cell lines from 26 individuals: 13 with cytogenetically
normal karyotypes, nine with the t(11;22)(q23;q11)-balanced
translocation, and four with the +der(22)t(11;22)(q23;q11) kar-
yotype (Emanuel syndrome patients) (see Supplemental Table S1
for the complete list of cell lines; see Methods for details).
Emanuel syndrome patients show significant changes in gene
expression as compared with controls
Comparison of unbalanced individuals with controls revealed
significantly more transcript expression changes than the bal-
anced versus control comparison (312 and 116 transcripts, re-
spectively, when considering only the most variable transcripts;
1313 and 985 transcripts, respectively, when considering all tran-
scripts; see Methods). This was anticipated, since Emanuel syn-
drome patients are partially trisomic for HSA11 and HSA22 and are
phenotypically affected (Fraccaro et al. 1980; Zackai and Emanuel
1980) (see OMIM no. 609029 for phenotype details; see Supple-
mental Fig. S1 for karyotype). Indeed, a statistically significant
fraction of the differentially expressed transcripts mapped to these
two chromosomes (Fig. 1A–D) (e.g., 10 transcripts, half mapping to
HSA11 and half to HSA22 among the top 25-ranked compared with
the expected 1.2 [P < 0.01] and 0.5 [P < 0.0003], respectively, Fisher’s
exact test; see Supplemental Table S2 for details). Consistently, all
differentially expressed genes that map to the trisomic regions of
chromosome 11 and 22 and are ranked in the top 100 most differ-
entially expressed transcripts show an increase in expression levels
in cells of Emanuel syndrome patients (Fig. 1D). The comparison
between unbalanced and controls was performed as an internal
control and possible links between dysregulated genes and the
Emanuel syndrome phenotype will be discussed elsewhere.
To confirm our results, we performed quantitative PCR (Merla
et al. 2006; Molina et al. 2008) on a total of 14 different cell lines
from the three different genotypes (four Emanuel syndrome, five
t(11;22) carriers, and five control cell lines) to determine the rela-
tive expression levels of 10 genes that appeared to show modified
expression in the cell lines of Emanuel syndromepatients, butnot of
translocation carriers. Eight of these genes (four on HSA11 and four
on HSA22) are trisomic in the patients (genes and assays used are in
Supplemental Table S3). The results are consistent with the data
obtained using the expression microarrays (correlation coefficient,
R2 = 0.96). For example, the trisomic transcripts are expressed on
average 1.64-fold (SD = 0.30) more in cells of Emanuel syndrome
patients as compared with normal controls (Supplemental Fig. S2).
Balanced individuals show gene expression changes
as compared with controls
To assess whether the number of differentially expressed tran-
scripts between controls and balanced t(11;22) individuals was
significant, or whether it could be reached by sampling the control
population alone, we randomly permuted the labels of the control
and balanced samples 1000 times (results were comparable using
as few as 10 permutations), and each time computed the number
of differentially expressed transcripts using a standard t-test, thus
providing an empirical distribution of this metric (Fig. 2A). To
prevent bias due to an arbitrary choice of significance threshold,
several different P-value cutoffs were used (19 thresholds between
106 and 1). The number of differentially expressed transcripts
between unbalanced versus full-genome complement cohorts
(unbalanced vs. others), and male versus female or young versus
old cohorts were also computed for reference (Fig. 2A). As expected
(see above), we found a significant number of differentially ex-
pressed transcripts when comparing transcriptomes of Emanuel
syndrome patients with those of balanced and controls together
(unbalanced vs. others comparison). Similarly, the male versus
female comparison revealed a significant number of transcripts
showing differential expression between the genders. Reasoning
that a substantial proportion of these would map to the sex
chromosomes, we replicated our analyses, removing this bias by
considering only autosome-mapping transcripts (Fig. 2B; Supple-
mental Figs, S3, S4, S5). This showed that the total number of au-
tosomal transcripts differentially expressed between male and fe-
male samples was not significant and could be achieved by chance
alone. On the other hand, comparison of individuals with and
without the t(11;22) translocation (controls vs. balanced) showed
numbers of differentially expressed transcripts that ran along the
upper limit of the area containing 95% of the permutation distri-
bution corresponding to the conventional P-value threshold of
0.05 (Fig. 2), and thereby closely bordering significance (e.g., at
threshold 0.01 to call a gene differentially expressed, we observe
16 differentially expressed genes, corresponding to the top 3% of
the permutation results). The number of differentially expressed
transcripts between the two groups with complete genome com-
plements is therefore large enough to place t(11;22) carriers at one
tail of the normal transcriptome profile distribution (Fig. 2). This
indicates that balanced rearrangements have a greater effect on
gene expression than normal variation, and that these individuals
show a greater degree of gene expression changes than would be
expected given their apparently normal phenotype.
Examination of the fold changes for the most differentially
expressed genes between controls and balanced translocation
carriers showed that they are for the greater part up-regulated (e.g.,
73 up-regulated genes out of the top 100) and are distributed
throughout the genome, with genes being located on almost every
chromosome (Fig. 1E). Interestingly, some of these genes map to
contiguous chromosomal regions, indicating that they may be
under a common mechanism of expression modulation (Fig. 1F).
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Figure 1. Mapping of t(11;22) and Emanuel syndrome differentially expressed genes. Ensembl Karyoview ideograms showing the chromosomal
location of the top 100 differentially expressed genes between Emanuel patients (unbalanced) and controls (A–D) and between carriers of the balanced
t(11;22) translocation and controls (E–G). Complete karyograms are shown in A and E, while detailed views of chromosomes 11 and 22 are shown in B and
F, and C and G, respectively. The derivative chromosome 22, which corresponds to the trisomic regions in Emanuel syndrome patients, is shown in D. The
blue lines indicate the translocation breakpoints. Green arrowheadsmark the genes showing an increase in expression in cell lines from Emanuel syndrome
patients (A–D) and translocation carriers (E–G), while red arrowheads depict those showing a decrease.
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For example, the group of genes located in the region 11q23.1-q25
show more differential expression than would be expected by
chance (P = 0.03; software developed at the Swiss Institute of Bio-
informatics and implementing the GSEA algorithm) (Subramanian
et al. 2005). If changes in gene expression between controls and
translocation carrying cells were caused solely by physical separation
of cis-acting regulatory elements, we would expect an enrichment of
affected genes close to the breakpoints on
HSA11 and HSA22. This was not the case.
On the contrary, we find genes with
modified expression mapping tens of
megabases from the breakpoints, on the
opposite arm of the chromosome or on
different chromosomes altogether (Fig.
1E–G; Supplemental Fig. S6). Furthermore,
this separation, termed ‘‘position effect’’ or
‘‘cis-ruption’’ (Kleinjan and vanHeyningen
2005; Kleinjan and Coutinho 2009), can-
not explain why transcripts mapping to
HSA11, but not HSA22, are over-repre-
sented amongst affected transcripts (e.g.,
four transcriptsmapping to HSA11 among
top 25-ranked compared with the expec-
ted 1.2 [P < 0.04, Fisher’s exact test] and no
HSA22 transcripts [expected 0.5, P = 1; see
Supplemental Table S4 for details]).
The derivative chromosomes occupy
different nuclear positions than their
normal counterparts
Since chromosome position within the
nucleus is nonrandom and a previous
study has shown that a different balanced
translocation, also involving HSA11 and
HSA22, and present in over 85% of Ewing
sarcomas, modified the position of the
derivative chromosomes within the in-
terphase nucleus (Taslerova et al. 2003,
2006), we reasoned that repositioning of
the derivative chromosomes 11 and 22
could be the basis of the perturbed gene
expression that we observed. We there-
fore used interphase fluorescence in situ
hybridization (FISH) to measure the re-
lative position of HSA11, HSA22, deri-
vative 11, and derivative 22 chromo-
somes in lymphoblastoid nuclei from
multiple controls and translocation car-
riers. To determine the positions of the
normal and derivative chromosome 11,
we used a chromosome 11–specific paint
andBAC clone RP11-422P18 thatmaps to
22q12, just distal to the translocation
breakpoint (Table 1; Fig. 3A). In nuclei
from seven different control lympho-
blastoid cell lines, HSA11 occupied, on
average, a position midway between the
center and the edge of the nucleus, as
previously described (Fig. 3C; Boyle et al.
2001). In nuclei from four balanced
t(11;22) cell lines, the normal HSA11 had
a nuclear distribution similar to that found in control cell lines.
However, the distribution of the derivative 11 territory was shifted
significantly toward the center of the nucleus as compared with the
normal HSA11 (P = 0.00073, permutation test with Kolmogorov-
Smirnov statistics; Fig. 3C). In contrast, the 22q BAC signal was
located toward the center of the nucleus in both control and
t(11;22) cells when marking the normal HSA22, consistent with
Figure 2. Numbers of differentially expressed transcripts between t(11;22) carriers and control in-
dividuals. Graphs showing the number of differentially expressed transcripts between the studied co-
horts identified with variable P-value thresholds and mapping on all (A) or autosomal only (B)
chromosomes. Axes are in log scale. The following comparisons are shown: balanced [i.e., t(11;22)
carriers] versus control cohorts (red line; nine vs. 13 samples), male versus female cohorts (blue line; six
vs. 16 samples), young versus old cohorts (green line; nine vs. 13), and unbalanced (Emanuel syndrome
patients, with partial trisomy 11 and 22) versus full-genome complement cohorts (unbalanced [four] vs.
others [22]; orange line). Note that the sex and aneuploid/euploid comparisons are provided for in-
formation only. They involve different numbers of samples and therefore cannot be directly compared
with the ‘‘balanced versus control’’ statistics or to the permutation distribution (see below). These two
comparisons and the age comparison are comparedwith their own permutation results in Supplemental
Figures S3, S4, and S5. The gray lines and shaded area represent 50%, 70%, 90%, and 95% of the
permutation distribution (nine vs. 13; see main text for details). We observe that the number of tran-
scripts differentially expressed between the control and the balanced cohorts follows the line de-
marcating 95%of the permutations, suggesting that t(11;22) carriers are at one tail of the distribution of
transcriptome profiles.
Translocation and expression
Genome Research 557
www.genome.org
the known central location of chromosome 22 (Boyle et al. 2001),
but shifted to a significantlymore peripheral positionwhen on the
derivative 11 (P = 0.002; Fig. 3D).
To examine the part of 11q that is distal to the translocation
breakpoint at 11q23, we used BAC RP11-93E4 that maps to 11q24
(Table 1; Fig. 3B). This portion of the genome is relocated to amore
internal nuclear position when on the derivative 22, relative to its
position onnormalHSA11 (Fig. 3E). Because of the central position
of chromosomes 22 within the nuclei of lymphoblastoid cells
(Boyle et al. 2001) and their close association with the nucleolus,
we were unable to use a chromosome 22–specific paint to distin-
guish the normal and derivative 22 in the same nucleus. However,
we could not detect a significant difference in the nuclear position
of a BAC on the derivative 22 (Fig. 3E) and the BAC that detects the
normal HSA22 (Fig. 3D). Therefore, we conclude that the normal
and derivative chromosome 22 do not significantly differ in their
nuclear position. This may be because the derivative 22 retains the
ribosomalDNA (rDNA) arrays on the p arm, thereby anchoring this
chromosome in the nucleolus.
This (re)positioning of the derivative chromosomes is con-
sistent with the change in gene density within a 2-Mb window
around the breakpoints, which has been shown to be a good pre-
dictor of radial chromosome positioning within lymphoblastoid
nuclei (Boyle et al. 2001; Murmann et al. 2005; Federico et al.
2008). The transposition of the derivative chromosome 11 to
a more central position within the nucleus results in HSA11 genes
retained on this chromosome being placed into an anomalous
chromatin environment, potentially causing changes in their level
of expression. Similarly, HSA11 genes located distal to the break-
point, which therefore map to the derivative 22, are also relocated
to a more central position. Conversely, HSA22 genes that map to
the derivative 11 show a shift to a more peripheral position than
those on the normalHSA22. The fact that only a limited number of
genes on the rearranged chromosomes are detectablymisexpressed
is consistent with previous studies in which chromosome position
was experimentally manipulated (Finlan et al. 2008; Reddy et al.
2008). Both these ‘‘tethering’’ experiments and our analyses sug-
gest that not all genes in the genome are sensitive to their nuclear
environment. However, we note that the observed changes in
expression are effective even with a single erroneously positioned
allele, suggesting that nuclear chromosome organization has
a substantial influence on the regulation of gene expression.
Chromosomes not involved in the translocation also show
nuclear position changes
To determine whether the position of other chromosomes within
the nucleus is affected in cells frombalanced translocation carriers,
we repeated our FISH analysis using a chro-
mosome 17-specific paint. The results showed
that HSA17, a gene-dense chromosome, is
shifted to a significantly more peripheral po-
sition in balanced cell lines as compared with
controls (Fig. 4A; Kolmogorov-Smirnov sta-
tistics, P = 0.03). This suggests that movement
of the large derivative 11 to a more central
position has a knock on effect that results in
displacement of other chromosomes from
their usual nuclear positions.
The repositioning of the derivative and
other chromosomes within the nucleus and
associated changes in gene expression may
have many causes. The most active chromosomes are situated at
the nuclear center (Boyle et al. 2001) and active and inactive copies
of monoallelically expressed genes occupy different positions
within the nucleus (Takizawa et al. 2008). The placement of genes
into anomalous chromatin environments or their relocation rela-
tive to the center or periphery of the nucleus can affect their ex-
pression, and gene expression levels have been shown to be
reduced or increased in correlation with movement toward the
nuclear periphery or interior, respectively (Williams et al. 2006;
Finlan et al. 2008; Reddy et al. 2008; Szczerbal et al. 2009). Con-
sistently, we observed that all HSA11-mapping genes that belong
to the 100 most differentially expressed genes in t(11;22) cells
showed increased expression levels concomitant to their move-
ment to a more central nuclear location (see Fig. 1E,F). Although it
appears that HSA22 genes that map to the derivative 22 chromo-
some do not show a significant change in their nuclear location as
compared with those on the normal HSA22 (although given that
chromosome 22 paint could not be used in this study, we have not
mapped the full extent of the derivative chromosome 22 territory),
those genes that show differential expression may still have un-
dergone a shift in their position, as genes can loop out from their
chromosome territory, and the repositioning of whole chromo-
some territories has been shown to be less dramatic than that of
individual gene loci (Szczerbal et al. 2009). Differentially expressed
HSA22 genes that map to the derivative 22 may, therefore, have
undergone an alteration in their position that coincides with their
observed expression changes.
Differentially expressed genes show position changes
within the nucleus
To determine whether individual differentially expressed genes
were repositioned within the nucleus, we repeated the FISH anal-
yses using four different fosmid probes that cover three genes
differentially expressed in cell lines from balanced individuals as
compared with controls, and one control gene that did not show
any expression differences between these cohorts (fosmid coor-
dinates and mapping positions are shown in Table 1 and Supple-
mental Fig. S6, respectively). The fosmids mapping to differentially
expressed genes showed slight, yet not significant (Kolmogorov-
Smirnov statistics) nuclear position changes (Fig. 4B–D), whereas
the fosmid covering the control gene showed no alteration in po-
sition (Fig. 4E). This adds to the growingbodyof evidence suggesting
that changes in nuclear position are linked with gene expression
changes. Our results only partially agree with the view that increases
in gene expression correlate with a shift toward the center of the
nucleus, and vice versa (Williams et al. 2006; Finlan et al. 2008;
Reddy et al. 2008; Szczerbal et al. 2009), as fosmids F11 and D5,
Table 1. List of BAC and fosmid clones used for FISH analysis
Gene covered/
BAC name
Chromosome
band Coordinates Fosmid names
RP11-422P18 22q12 Chr22:20,761,005–20,909,256a
RP11-93E4 11q24 Chr11:122,620,175–122,768,650a
HNRPK 9q21.32 Chr9:85,759,086–85,796,457b G248P81402D5 D5
USP28 11q23.2 Chr11:113,206,314–113,248,959b G248P8942D11 D11
MAPK1 22q11.21 Chr22:20,457,269–20,499,174b G248P84992F11 F11
CRYBB1 22q12.1 Chr22:25,312,744–25,353,970b G248P87917B7 B7
aFrom Ensembl release 55, July 2009.
bFrom the UCSC Genome Browser, Human Mar 2006 Assembly (hg18).
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Figure 3. (Legend on next page)
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which map to genes showing an increase and decrease in expres-
sion, respectively, are concomitantly shifted more centrally and
more peripherally. On the contrary, fosmid D11 moves to a more
peripheral position within the nucleus, despite it mapping to a gene
showing an increase in expression.
The reorganization of chromosomes within the nucleus may
result in disruption of cis interactions. A recent comprehensive
mapping of long-range interactions revealed that intrachromo-
somal contacts decreased as a function of genomic distance reach-
ing a plateau at 90 Mb in lymphoblastoid cells (Lieberman-Aiden
et al. 2009). Co-associations of genes situated 25-Mb apart on
the same chromosome (Osborne et al. 2004; Simonis et al. 2006;
Mitchell and Fraser 2008) have also been shown to occur at ‘‘tran-
scription factories’’—discrete foci within the nucleus that contain
high concentrations of active RNA polymerase II, at which actively
transcribed alleles have been shown to be positioned (Iborra et al.
1996; Osborne et al. 2004)—or around aggregations of splicing-
related factors, termed ‘‘Nuclear Speckles’’ (Brown et al. 2008;
Sutherland and Bickmore 2009). Interactions are not restricted to
those genes situated on the same chromosome—trans interactions
have also been reported (Lieberman-Aiden et al. 2009) and may be
supposed to have a functional basis (Misteli 2004; Osborne et al.
2007). Thus, relocation of not only the derivative chromosomes,
but also other chromosomes within the nuclei of cells from bal-
anced translocation carriers, may disrupt some of these interac-
tions. The cis and trans interactions that occur at these specific foci
could also explain why genes differentially expressed between bal-
anced translocation carriers and controls mapped not only to the
derivative chromosomes but to nearly every chromosome. These
genes are then likely to modify the expression of other downstream
targets, further extending the number of affected genes and their
respective mapping positions.
While we speculate thatmany of the gene expression changes
we observe are a direct consequence of nuclear reorganization
caused by the altered positioning of the translocation chromo-
somes within the nucleus, we cannot exclude that they are caused
by other facets of genome structure and function, such as repli-
cation timing, which also correlate with nuclear position and
repositioning (Hiratani et al. 2008).
Here, we have shown large-scale changes in gene expression
concurrent with translocation-induced nuclear repositioning. Al-
though carriers of the balanced t(11;22)(q23;q11) are generally
phenotypically normal, we note that there are reports of in-
creased cancer incidence in these carriers (Lindblom et al. 1994;
Jobanputra et al. 2005;Wieland et al. 2006; Carter et al. 2010), and
speculate that the altered gene expression we observe may under-
lie this. Furthermore, our observations raise the possibility that
translocations in cancer cells may contribute to oncogenesis not
only by disrupting the gene, or genes mapping around the break-
points, but also through changes in expression of genes positioned
elsewhere on the affected chromosomes and on other displaced
chromosomes, a hypothesis that warrants detailed investigation
in the future. Our results could also have implications on repro-
ductive separation. Major genome rearrangements may play im-
portant roles in sympatric and parapatric speciation, a phenome-
non known as chromosome speciation (for review, see Ayala and
Coluzzi 2005; Noor and Feder 2006) and balanced transloca-
tions have been shown to reinforce the reproductive isolation of
Saccharomyces species (Delneri et al. 2003). It was postulated that
natural selection can fix such changes because they confer adap-
tive significance either through changes in expression of specific
genes or possibly by modifying the structure of the implicated
chromosomes themselves (Perez-Ortin et al. 2002; Colson et al.
2004). Consistently, Margue`s-Bonet et al. (2004) found that genes
mapping on chromosomes rearranged between human and chim-
panzee showed more varied relative expression levels between the
two species than genes situated on colinear chromosomes. Here,
we show that the human t(11;22) balanced translocation modifies
the relative expression levels of a significant number (2%–3%) of
expressed transcripts. Our results, therefore, suggest that in verte-
brates a single major genome rearrangement (e.g., a translocation)
may provide both a selective advantage and a genetic barrier with-
out the requirement of secondary changes.
Methods
Cell culture
Age and sex matched lymphoblastoid cell lines were obtained
from either the Coriell Institute for Medical Research (http://www.
coriell.org/), the European Collection of Cell Cultures (ECACC;
http://www.ecacc.org.uk/), or from Elisabeth Blennow at the
Karolinska Institute, Stockholm. A complete list of cells is shown
in Supplemental Table S1. Appropriate informed consent was ob-
tained for each sample by the physician in charge. All cells were
cultured in RPMI-1640 Medium with GlutaMAX (GIBCO, Invi-
trogen), supplemented with 10% (v/v) Fetal calf serum, and 1%
(v/v) penicillin and streptomycin at 37°C in 5% CO2. DNA was
extracted from each cell line of the sample population using the
Nucleon BACC genomic DNA extraction kit (GE Healthcare) ac-
cording to the manufacturer’s instructions. The absence of DNA
sequence loss, as well as the presence/absence of derivative 11 and
derivative 22 chromosomeswere assessedwith PCR assays using the
following pairs of primers that map near to the HSA11 and HSA22
breakpoints: primer pair c14irev GGAAGTTAGAGAAAACTGAGAA
Figure 3. Nuclear position of normal and derivative chromosome territories in t(11;22) cells and control cell lines. BAC coordinates are shown in Table
1. (A) Chromosome ideograms and schematic representation of the regions recognized by FISH probes used to distinguish the normal and derivative
chromosome 11s, and an example of FISH on lymphoblastoid cells from a t(11;22) carrier. (Green) Chromosome 11 paint; (red) BAC RP11-422P18. DNA is
counterstained with DAPI (blue). In nuclei of cells carrying the balanced t(11;22), the normal HSA11 is marked solely by the green chromosome paint
signal, whereas the green painted territory for the derivative chromosome 11 is also associated with a red BAC hybridization signal. The normal HSA22 is
indicated by a lone red BAC signal. (B) As in A, but chromosome 11 paint is in red and BAC RP11-93E4 is in green. In nuclei of cells carrying the balanced
t(11;22), the normal HSA11 is marked by the red chromosome paint signal associated with a green BAC hybridization signal, whereas the derivative
chromosome 11 is marked solely by the red painted territory. The derivative chromosome 22 is indicated by a lone green BAC signal. (C ) Mean (+ SEM)
percent of chromosome 11 paint hybridization signal present in five shells of equal area eroded from the edge (shell 1) to the center (shell 5) of the nucleus
in seven control cell lines of normal karyotype (left) and four t(11;22) cell lines (right), showing the relative positions of the normal (blue) and derivative
chromosome 11 (green). n = 40–50 nuclei each for each cell lines. The derivative 11 territory is shifted to a more central position in the nucleus compared
with the normal 11. (D) As in C, but using BAC RP11-422P18 on four normal cell lines (left) and four t(11;22) cell lines (right) to compare positioning of the
normal chromosome 22 (red) from that of the derivative 11 (green). The BAC signal on the derivative 11 is situated in amore peripheral position than that
on the normal chromosome 22. (E) As in C, but using BAC RP11-93E4 on four normal cell lines (left) and five t(11;22) cell lines (right) to compare
positioning of the normal chromosome 11 (blue) from that of the derivative 22 (yellow). The BAC signal on the derivative 22 is situated in a more central
position than that on the normal chromosome 11.
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and JF22.2 CCTCCAACGGATCCATACT; and primer pair JF22.2
CCTCCAACGGATCCATACT and c14hfor AACACTCCCACTGAC
AGCTA (see Kurahashi et al. 2000a,b; Kurahashi and Emanuel
2001). The amplification reactions were performed as follows:
95°C for 5 min; five cycles of 94°C for 30 sec, 58°C for 30 sec, and
72°C for 1 min; followed by 35 cycles of 94°C for 30 sec, 56°C for
30 sec, and 72°C for 1 min; and 72°C for 5 min.
RNA isolation and expression array
Total RNAwas extracted using TRIzol reagent (Invitrogen), cleaned
on RNeasy columns (Qiagen) according to the manufacturers’ in-
structions and used as a template for complementary DNA (cDNA)
synthesis and biotinylated antisense cRNA preparation. The syn-
thesis of cDNA and cRNA, labeling, hybridization, and scanning of
the samples were performed as described by Affymetrix (http://
www.affymetrix.com). GeneChip Human Genome U133 Plus 2.0
arrays, each interrogating over 47,000 target sequences with ap-
propriate probesets (Affymetrix) were used to hybridize the labeled
cRNA. Lymphoblastoid cell lines established from blood samples
of individuals with normal (13 samples), balanced (nine), or un-
balanced (four) karyotypes were processed for a total of 26 ex-
pression arrays. These data have been deposited in the NCBI Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and are
accessible through GEO series accession number GSE13122.
Expression data analyses were performed using R (version
2.7.1) (The R Development Core Team 2004) and bioconductor
(Gentleman et al. 2004). Low-level analysis and normalization
were done using RMA (bioconductor package affy, version 1.16.0)
(Irizarry et al. 2003). Two datasets were analyzed: In addition to the
complete set of target sequences (transcripts), a filtered data set
that included only target sequences with hybridization signals
with standard deviation over all samples greater than 0.5 was also
created. For differential expression analysis, the following two
pairwise comparisons were performed: control versus balanced,
and as an internal control, control versus unbalanced. The number
of differentially expressed transcripts in each comparison was de-
termined using the moderated t-statistic provided by the limma
package (version 2.14.5) (Smyth 2004, 2005). A threshold of P <
0.01was used;multiple testingwas accounted for by correcting the
P-values using the Benjamini and Hochberg (1995) method to
control the false discovery rate (FDR). Genome mapping of the
expressed transcripts was determined following version na22
(March 9, 2007) of the annotation provided by Affymetrix. To as-
sess whether the number of differentially expressed transcripts
between the two groups with full-genome complements was sig-
nificant and could not be reached by chance alone (controls vs.
balanced comparison, Fig. 2), we performed a permutation test.We
randomly permuted the labels of the control and balanced samples
1000 times, and each time computed the number of differentially
expressed transcripts using a standard t-test, thus providing an
empirical distribution of this metric (Fig. 2). To prevent bias due
to an arbitrary choice of significance threshold, several different
P-value cutoffs were used (19 thresholds between 106 and 1; Fig.
2). No correction for multiple testing was performed, since the
permutation distribution already provides an assessment of the
expected number of significant results obtained by chance. We
note that tests performed with only 10 and 100 permutations gave
similar results.
Quantitative PCR
Quantitative PCR was performed using SYBRGREEN PCR Master
Mix (Applied Biosystems) following the manufacturer’s specifica-
tions. Oligonucleotides were designed using the Primer3 program
with default parameters (Supplemental Table S3). The efficiency of
each assay was tested in a cDNA dilution series as described (Livak
and Schmittgen 2001). All RT-PCR reactions were performed in
a 10-mL final volume and three replicates per sample and set up in
a 384-well plate format using a Freedom EVO robot (TECAN) and
run in an ABI 7900 Sequence Detection System (Applied Bio-
systems) with the following amplification conditions: 50°C for 2
min, 95°C for 10min, and 50 cycles of 95°C 15 sec/60°C for 1min.
Each plate included the appropriate normalization genes to con-
trol for any variability between the different plate runs. Raw
threshold cycle (CT) values were obtained using SDS2.2 (Applied
Biosystems). To calculate the normalized relative expression ratio,
we followed the method described in Merla et al. (2006) and
Molina et al. (2008), and exploited the geNorm method to select
GUSB, SDHA, andTBP as normalization genes (Vandesompele et al.
2002). Relative expressions were measured in four cell lines from
Emanuel syndrome patients, five from t(11;22) carriers, and five
from controls.
Fluorescence in situ hybridization
A complete list of the BACs and fosmid clones used for this report is
shown in Table 1. They were obtained from BACPAC Resource
Center (BPRC) at the Children’s Hospital Oakland Research In-
stitute. Clones were grown and DNA extracted according to BPRC
protocols. Chromosome paints were a kind gift from J. Trent (TGen,
Pheonix, AZ). FISH probes were produced and FISH performed on
fixed cell suspensions according to standard methods (Guan et al.
1996;Chong et al. 1997). Image capture and analyseswere performed
using in-house scriptswritten for IP Lab Spectrum(ScanalyticsCorp.).
The radial positions of the chromosome territories and BAC
and fosmid clones were determined using an adaptation of a
method previously described (Boyle et al. 2001; Finlan et al. 2008). A
total of 40–50 nuclei for each of three to seven different cell lines
were analyzed per experiment and five shells (annuli) of equal area
Figure 4. Nuclear position of chromosome 17 territories and fosmids covering differentially expressed genes in normal and t(11;22) cells. The fosmid
coordinates and mapping positions are shown in Table 1 and Supplemental Figure S6, respectively. (A) Mean (+SEM) percent of chromosome 17 paint
hybridization signal present in five shells of equal area eroded from the edge (shell 1) to the center (shell 5) of the nucleus in four control cell lines of normal
karyotype (dark purple) and five t(11;22) cell lines (light purple) showing the relative positions of the chromosome 17s. n = 40–50 nuclei each for each cell
lines. The chromosome 17 territory is shifted to amore peripheral position in nuclei from balanced translocation carriers as compared to controls. (B) Mean
(+SEM) percent of the hybridization signal of chromosome 9q21.32 fosmid G248P81402D5 (D5) in four control cell lines of normal karyotype (dark blue)
and four t(11;22) cell lines (pink) showing the relative positions of the fosmid. The fosmid signal is shifted to a slightly more peripheral position in nuclei
from balanced cell lines as compared with controls. (C ) As in B, but using fosmid G248P8942D11 (D11) on three control cell lines of normal karyotype
(right) and four t(11;22) cell lines (left), showing the relative positions of the fosmid on the normal 11 (blue) and on the derivative chromosome 11 (green).
The fosmid signal on the derivative 11 is shifted to a slightly more peripheral position than that on the normal 11. (D) As in B, but using fosmid
G248P84992F11 (F11) on three control cell lines (left) and four t(11;22) cell lines (right), showing the relative positions of the normal 22 (red) and the
derivative 11 (green). The fosmid signal on the derivative 11 is shifted to a slightly more central position than that on the normal 22. (E ) As in B, but using
fosmid G248P87917B7 (B7) on four control cell lines (left) and five t(11;22) cell lines (right), showing the relative positions of the normal 22 (red) and the
derivative 11 (green). This fosmid covers a gene that does not show any differential expression between balanced translocation carriers and controls and
the fosmid signal on the derivative 11 shows no difference in position compared with that on the normal 22.
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were calculated from the periphery (annulus 1) to the center (an-
nulus 5) of the nucleus based on the segmentedDAPI signal. Signals
were treated independently. An area of interest was drawn around
the relevant signal and the mean proportion (%) of hybridization
signal in each annulus calculated and normalized to the proportion
of hybridization signal for that fluorochrome in the whole nucleus.
The difference between the two distributions of positions (averaged
over the replicates) was assessed using the cumulative proportions
of hybridization signal and a Kolmogorov-Smirnov statistics. Sig-
nificance was determined by performing a permutation test over all
possible permutations.
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